Australia markets closed

GeoVax Labs, Inc. (GOVX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.6800-0.0400 (-2.33%)
At close: 04:00PM EDT
1.6716 -0.01 (-0.50%)
After hours: 05:16PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.7200
Open1.7500
Bid0.0000 x 0
Ask0.0000 x 0
Day's range1.6800 - 1.8100
52-week range1.6400 - 11.5350
Volume11,578
Avg. volume41,919
Market cap3.649M
Beta (5Y monthly)2.92
PE ratio (TTM)N/A
EPS (TTM)-14.2900
Earnings date02 May 2024 - 06 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est76.25
  • GlobeNewswire

    GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine

    Presentation Made During the 24th Annual World Vaccine Congress ATLANTA, GA, April 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that its Chief Scientific Officer, Mark Newman, PhD, presented data on GEO-CM04S1, the Company’s next-generation Covid-19 vaccine candidate, during the 24th Annual World Vaccine Congress in Washington, DC. During

  • GlobeNewswire

    GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress

    ATLANTA, GA, March 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that its Chief Scientific Officer, Mark Newman, PhD, will present data on GEO-CM04S1, the Company’s next-generation Covid-19 vaccine candidate, during the upcoming 24th Annual World Vaccine Congress taking place in Washington, DC on April 1-4, 2024. Presentation Details:Present

  • GlobeNewswire

    GeoVax to Present at the 36th Annual Roth Conference

    ATLANTA, GA, March 12, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today that its Chairman and CEO, David Dodd, will present at the 36th Annual Roth Conference, taking place in Dana Point, CA on March 17-19, 2024. Presentation Details: Presenter: David Dodd, Chairman & CEODate/Time: March 18, 2024, 2:30 pm PTLocation: Dana Point, CAWebcast Link: Ro